Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Registry of People With Obesity Treated With Traditional Chinese and Western Medicine

Follows adults with obesity receiving combined traditional Chinese and Western medicine care.

Plain-language title generated from the registry record
Registry title: Real-World Case Registry Study on Obesity

Key facts

Where
Wuhan, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT07448090, who can take part

Where in China

  • Hubei Provincial Hospital of Traditional Chinese MedicineWuhan, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Hubei Hospital of Traditional Chinese Medicine
Trial code
NCT07448090
Record updated
12 June 2026
Original description
Obesity is a major risk factor for cardiovascular disease, diabetes, cancer, and other chronic conditions. Due to its complex etiology and frequent comorbidities, effective obesity management requires comprehensive and individualized approaches. This study is a multicenter, prospective, real-world registry designed to evaluate integrated traditional Chinese medicine (TCM) and Western medicine interventions for obesity.Read full original descriptionShow less

Real-World Case Registry Study on Obesity

Obesity is a major risk factor for cardiovascular disease, diabetes, cancer, and other chronic conditions. Due to its complex etiology and frequent comorbidities, effective obesity management requires comprehensive and individualized approaches. This study is a multicenter, prospective, real-world registry designed to evaluate integrated traditional Chinese medicine (TCM) and Western medicine interventions for obesity.

The study will enroll at least 10,000 individuals with obesity from urban and rural populations. Multimodal data, including electronic medical records, laboratory test results, imaging data, and lifestyle information, will be collected. The effectiveness of integrated TCM and Western medicine interventions will be assessed across different age groups, disease stages, and obesity-related constitution types. In addition, disease progression patterns and key prevention and treatment points will be explored. Health economic analyses will be conducted to evaluate the cost-effectiveness of different obesity management strategies, providing real-world evidence to support public health policy and the optimization of integrated obesity prevention and management approaches.

Inclusion: Age 18 years and above, gender not restricted; Weight fluctuation within the last 3 months is ≤ 5% and BMI is ≥ 28.0 kg/m2; Good compliance, willing to follow the follow-up principles; Agree to sign the informed consent form.

Exclusion: Co-existing severe diseases of the heart, liver, lungs, kidneys, brain, blood, neuro-psychiatric system, or other vital organs; Secondary obesity (obesity attributable to another clearly diagnosed disorder, e.g., hypothalamic or pituitary inflammation, tumours or trauma, Cushing's syndrome, hypothyroidism, hypogonadism, polycystic ovary syndrome, etc.); Iatrogenic obesity (obesity resulting from drugs or therapeutic interventions administered for other conditions); Pregnant or lactating women; Subjects whom the investigator deems unsuitable for participation in this study.

ClinicalTrials.gov NCT07448090